C30.1

Malignant neoplasm of middle ear

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC V28

HCC21

Lymphoma and Other Cancers

CMS-HCC ESRD V24

HCC11

Colorectal, Bladder, and Other Cancers

RxHCC V08

RXHCC22

Prostate, Breast, Bladder, and Other Cancers and Tumors

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · C30.1
Excludes 1

malignant neoplasm of auricular canal (external) (C43.2-,C44.2-) malignant neoplasm of bone of ear (meatus) (C41.0) malignant neoplasm of cartilage of ear (C49.0) malignant melanoma of skin of (external) ear (C43.2-) other and unspecified malignant neoplasm of skin of (external) ear (C44.2-)

Synonyms

Malignant neoplasm of antrum tympanicum Malignant neoplasm of auditory tube Malignant neoplasm of eustachian tube Malignant neoplasm of inner ear Malignant neoplasm of mastoid air cells Malignant neoplasm of tympanic cavity

Inherited from C30-C39Malignant neoplasms of respiratory and intrathoracic organs
Includes

malignant neoplasm of middle ear

Excludes 1

mesothelioma (C45.-)

Inherited from chapter 2Neoplasms
Note

Functional activity All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9). (C00-C96) Malignant neoplasms (C00-C96) (C00-C75) Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue (C00-C75)

Official Guidelines for C30.1

FY 2026 ›

In the Table of Neoplasms

One of them: Neoplasm, neoplastic > antrum(Highmore) (maxillary) > tympanicum, column Malignant Primary.

tympanicum in every column

This row belongs to tympanicum. Other sites sharing C30.1 may differ in the remaining columns — check the one in your documentation.

  • Malignant PrimaryC30.10.671HCC21maps to HCC21
  • Malignant SecondaryC78.394.209HCC17maps to HCC17
  • Ca in situD02.30.000maps to no HCC category
  • BenignD14.00.000maps to no HCC category
  • Uncertain BehaviorD38.50.000maps to no HCC category
  • Unspecified BehaviorD49.10.000maps to no HCC category

The column is chosen by the documentation, not by the coder. Behaviour follows the pathology report (Guideline I.C.2). Coefficients are Community, Non-Dual, Aged under CMS-HCC V28 PY2027. How these figures were derived.